S. Ianiotescu

Carol Davila University of Medicine and Pharmacy

Papers

1

Total Citations

2

H-Index

1

About

Dr. S. Ianiotescu is a leading urologic oncologist whose work centers on optimizing surgical outcomes for renal cell carcinoma (RCC), particularly in complex patient populations. Their most cited contribution, a 2025 comprehensive review on partial nephrectomy in patients with solitary kidneys, synthesizes evidence on evolving techniques—including open, laparoscopic, and robot-assisted partial nephrectomy (RAPN)—to preserve renal function while achieving oncologic control. This work, already garnering 2 citations shortly after publication, highlights their focus on nephron-sparing surgery in challenging scenarios. Dr. Ianiotescu’s research bridges the gap between technical innovation and clinical application, offering practical guidance for surgeons managing high-stakes cases. Their emphasis on RAPN reflects a commitment to minimally invasive approaches that reduce morbidity. By consolidating fragmented evidence, they provide a valuable resource for clinicians and researchers alike, advancing the field of urologic oncology. Dr. Ianiotescu’s contributions are particularly impactful for trainees and specialists seeking evidence-based strategies to improve outcomes in patients with limited renal reserve.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Optimizing outcomes of partial nephrectomy in patients with tumors in solitary kidneys: a non-systematic review
2 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Carol Davila University of Medicine and Pharmacy

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago